Drug Pipeline

Firsekibart Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-04 NCT07625514 24-Week Recurrence Rate of Gout Following Firsekibart Treatment Not Yet Recruiting
Active Studies by Phase
Phase 4
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07381465 Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus Lupus Erythematosus, Systemic Not Yet Recruiting
Not specified
NCT07191444 A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease Still's Disease, Adult-Onset Recruiting
NCT07625514 24-Week Recurrence Rate of Gout Following Firsekibart Treatment Gout Flare Not Yet Recruiting
Sponsors Running Firsekibart Trials
Ruijin Hospital (1) Chinese SLE Treatment And Research Group (1) Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Disease Areas
Lupus (SLE) (1)
Get alerts when Firsekibart trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free